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ABSTRACT 
Background:  Probiotic  strains  of  bacteria  can  prevent  Salmonella  from  causing  disease  by 
preventing the pathogen from colonizing the intestines. Two strains of probiotics, Lactobacillus 
acidophilius and Pediococcus spp, that were obtained from poultry fecal samples have been 
shown to be efficacious in poultry. The objective of this study was to determine if these strains of 
probiotics could prevent salmonellosis in a mouse model.  
 
Methods:  First, both strains of probiotics were evaluated for in vitro efficacy to inhibit the 
growth  of  and  interfere  with  virulence  gene  regulation  in  Salmonella  enterica.  For  in  vivo 
efficacy,  mice  was  used  which  models  Typhoid  illness.    Mice  were  divided  into  2  groups: 
Control and treatment, Lactobacillus and Pediococcus (LP; 10
8 Log CFU). Two experiments 
were conducted. In the first experiment, the mice were treated with LP in water for the first two 
days of the experiment and challenged with Salmonella at day three. In the second experiment, 
the LP treatment was given in the water for 10 days and challenge was performed on day 11. In 
both experiments, at day 20 post-challenge, all mice were sacrificed, intestinal tracts and organs 
removed and cultured for Salmonella.  
 
Results:  The  probiotic  strains  inhibited  the  growth  of  Salmonella  and  down-regulation  of 
virulence genes was noted, but dependent on the strain of Salmonella being evaluated. For the in 
vivo experiment, the probiotics did not afford the mice protection from infection and increasing 
the  length  of  time  the  probiotics  were  administered  did  not  improve  the  efficacy  of  the 
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Conclusions: It appears that these strains of probiotic bacteria are effective against Salmonella 
in vitro. However, these isolates did not afford protection from Salmonella infection to mice 
which may be due to host specifity as these isolates were obtained from poultry. 
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BACKGROUND 
Bacteria,  including  Salmonella,  are  becoming  resistant  to  antibiotics  making  treatment  more 
difficult  [1].  Furthermore,  antibiotics  are  retroactive  and  cannot  prevent  sequelae  including 
Reiter’s syndrome and reactive arthritis. Thus, prevention of infection is key to avoiding life long 
illnesses. Due to the development of antibiotic resistance, alternatives are being sought which 
include  probiotic  bacteria  and  vaccination.  With  some  consumers,  “all  natural”  prevention 
methods including probiotics have been more popular [2].   
Probiotic  bacteria  provide  a  number  of  benefits  to  the  host  including  protection  from 
pathogenic bacteria [3]. These bacteria protect the host through several mechanisms including 
competing  for  nutrients  and  niches  and  production  of  antimicrobial  substances  [4,5]. 
Furthermore, there is  evidence that probiotic bacteria can interfere with the gene expression 
pathways of pathogenic bacteria, which could render the pathogen unable to colonize and cause 
disease [6].   
The performance of probiotic strains may differ with usage in different animals because 
factors such as adherence sites vary between hosts [2]. It is understood that pathogenic bacteria 
can be host specific such is the case for many zoonotic bacteria including Salmonella. However, 
it has not been clarified if probiotic bacteria are also host specific. Previous research as well as 
our own, have demonstrated that a mixed culture of two strains of probiotics are effective at 
preventing  Salmonella  colonization  in  broiler  chicks  [7].  Given  the  proven  efficacy  of  the 
probiotic strains used in this study and the source (poultry), the objective of this study was to 
determine their ability to inhibit Salmonella using a Typhoid induced mouse model.  
 
METHODS  
Bacteria strains and in vitro characterization 
One strain of Lactobacillus acidophilus and one strain of Pediococcus spp. originally obtained 
from a poultry cecal sample [7] were the two probiotic bacteria evaluated in this work, were 
cultured individually in De Man, Rogosa and Sharpe broth (MRS; Thermo Scientific, Pittsburgh, 
PA) and incubated at 37°C for 24h. After incubation, the medium was passed through a 0.45m 
filter to produce the sterile spent medium. The pH of the medium was adjusted to 6.2 prior to 
use.  For growth inhibition assays, a total of 11 serovars consisting of 15 strains of S. enterica 
were utilized (Table 1).  
All Salmonella strains were initially cultured on MRS and incubated at 37◦C for 24h. After 
incubation, a loop of bacteria was inoculated into MRS broth and incubated in a shaking water 
bath at 37◦C for 3h. The cultures then were split into 3 equal aliquots and centrifuged at 8000 × g 
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spent medium from L. acidophilus or Pediococcus. The pH of the suspensions was measured 
using a pH meter (Denver Instruments, Bohemia, N.Y., U.S.A.) at specific time points (0, 2, 4, 6, 
8, 12, 16, 20, and 24 h).  
 
Table 1. A table of the Salmonella enterica serovars, the source of the strains and references 
describing characteristics of the strains utilized in this work. 
 
Salmonella enterica serovar  Source 
Reference 
 
S. Typhimurium DT104  Human infection  1 
S. Typhimurium ATCC 23595 (LT2)  Laboratory strain  8 
S. Typhimurium ATCC 14028  Laboratory strain  None 
S. Enteritidis (WT)  Human infection   None 
S. Enteritidis ATCC 13076  Human infection  None 
S. Kentucky  Poultry carcass  9 
S. Kentucky  Poultry carcass  9 
S. Seftenburg  Poultry farm  10 
S. Heidelberg  Poultry farm  10 
S. Mbandanka  Poultry carcass  11 
S. Newport  Poultry carcass  11 
S. Bairely  Poultry carcass  11 
S. Javana  Poultry Farm  10 
S. Montevideo  Swine farm  10 
S. Infantis  Poultry Farm  10 
 
For growth curves, triplicate 200 μL aliquots of the cell suspensions were placed into the 
wells of a 96 well flat bottom plate. The optical density of the suspensions was determined using 
a plate reader (ELX 800 Universal Plate Reader; Bio-Tek Instruments, Winooski, Vt., U.S.A.) 
every hour for a 24h time period at 590nm. At the conclusion of the 24h period, viability of the 
cultures was evaluated by culturing aliquots of the cell suspension on tryptic soy agar (TSA). 
 
Measurement of virulence gene expression 
For these experiments, the 3 strains of Salmonella Typhimurium listed in Table 1 were used 
because this serovar causes disease in mice. The suspensions of Salmonella were prepared in the 
sterile spent media produced by the probiotic bacteria as described in the previous section. The 
expression of hilA and invA were measured as we have previously described [12]. Briefly, at 
specific time points (0, 2, 4, and 24h) an equal volume of RNA protect bacterial reagent (Qiagen, 
Valenica, Calif., U.S.A.) was added to the wells of the 12-well plate containing the Salmonella 
suspensions. The entire sample was collected into a 2mL microfuge tube and allowed to stand at 
room temperature for 5 min. Subsequently, total RNA was extracted from the samples with the 
RNeasy mini kit (Qiagen) as directed by the manufacturer. After extraction, the RNA samples 
were subjected to a DNase treatment utilizing the Qiagen DNase kit (Qiagen) as directed by the 
manufacturer.  Prior  to  use  in  the  Real-Time  PCR  assay,  all  samples  were  quantified 
spectrophotometrically (Nanodrop ND-1000, ThermoScientific, Pittsburgh, Pa., U.S.A.). 
All qRT-PCR reactions were performed using the ABI 7100 (Applied Biosystems, Carlsbad, Functional Foods in Health and Disease 2014; 4(8):370-380                                                            Page 373 of 380 
Calif., U.S.A.). Sequences for the primer sets, hilA and InvA, were as we have described [12] and 
synthesized by Integrated DNA technologies (Coralville, Iowa, U.S.A.). For each reaction, a 
20μL total volume consisted of 10μL of EXPRESS SYBR Green ERTM qPCR SuperMix with 
Premixed ROX (Invitrogen, Carlsbad, Calif., U.S.A.), 0.5μL of EXPRESS SuperScript Mix for 
One-Step SYBR Green ER (Invitrogen), 500nM of each primer, 100ng of RNA template, and 
water to volume. The qRT-PCR reaction was optimized to the conditions of 50◦C for 5 min for 
the initial reverse transcriptase step. This was followed by 40 cycles of 95◦C for 15s, 55◦C for 
15s, and 68◦C for 20s with fluorescence being measured during the extension phase. Melting 
curves were conducted subsequently and consisted of 95◦C for 15 s, 60◦C for 20 min increasing 
by 0.5◦C per min to a final temperature of 95◦C. All reactions were performed independently and 
in triplicate. Samples were normalized using the 16S rRNA gene as an internal standard. The 
relative changes (n-fold) in hilA expression between the treated and nontreated samples were 
calculated using the 2−CT method as described by Livak and Schmittgen [13]. 
 
In vivo experiments 
For  in  vivo  experiments,  after  incubation,  a  100μl  loop  of  Lactobacillus  acidophilus  and 
Pediococcus  were  suspended  individually  into  phosphate  buffer  solution  (PBS,  Becton, 
Dickinson and Company, Sparks, MD USA) and vortexed vigorously.  The suspensions were 
standardized to 1.46 at 630 nm by spectrophotometry for a final concentration of 9 log
 CFU mL
-
1. The suspended probiotics were provided daily in the drinking water for the mice for a period of 
three days in the first experiment and for 10 days in the second experiment prior to Salmonella 
challenge.  
 
Animals and Housing 
Five  to  six  weeks-old  male  BALB/c  mice  were  purchased  from  Harlan  Laboratories 
(Indianapolis,  IN)  and  housed  individually  in  standard  cages.  Animal  experiments  were 
conducted  with  an animal  care protocol approved by  the  Institutional Animal Care and Use 
Committee  at  the  University  of  Tennessee,  Knoxville.  A  total  of  15  mice  were  randomly 
distributed into 2 groups: 1) control; standard rodent chow and no probiotic treatment; and 2) 
treatment;  Lactobacillus  and  Pediococcus  (LP)  and  standard  rodent  chow  delivering  the 
treatment in water.   
For challenge, a strain of Salmonella enterica  serovar Typhimurium DT104 was utilized 
that was initially cultured on tryptic soy agar (TSA, Becton, Dickinson and Company, Sparks, 
MD USA) and incubated at 37°C for 24h. After incubation, a 10μl loop of culture was inoculated 
into tryptic soy broth (TSB, Becton, Dickinson and Company, Sparks, MD) and incubated in a 
shaking water bath at 37°C overnight (12 hours). From this culture, 1mL was inoculated into 
fresh  TSB  and  incubated  in  a  shaking  water  bath  at  37°C  for  3h.  The  culture  then  was 
centrifuged at 8,000 x g for 5 min and the supernatant discarded. The culture was washed 3 times 
by resuspending the pellet in phosphate buffer solution (PBS, Becton, Dickinson and Company, 
Sparks,  MD)  and  centrifuging.  After  washing,  the  culture  was  finally  resuspended  in  PBS. 
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concentration of 8 log
 CFU mL
-1.  The three groups of mice were infected with 0.25 ml of the 
bacterial suspension (10
8 log
 CFU mL
-1) by gastric gavage.  
The treatment was delivered in water for 2 days (Experiment 1) or 10 days (Experiment 2) 
prior to challenge with Salmonella. After challenge with the Salmonella, mice droppings were 
collected daily and cultured for Salmonella. If adverse signs of health appeared, the mice were 
euthanized  before  schedule  and  organs  were  collected.  At  day  20-post  challenge,  surviving 
animals were sacrificed and the heart, lungs, spleen, liver, kidneys, small intestine and ceca were 
removed and cultured for Salmonella. 
 
Fecal samples and organs 
Prior to challenge, fecal samples were taken for two days, to ensure that the mice were free of 
Salmonella.  Samples  were  enriched  with  Tetratrionate  broth  base  (TET,  Thermo  Fisher 
Scientific, Remel Products,  Lenexa,  KS)  supplemented with iodine  solution  (Thermo  Fisher 
Scientific). The enriched samples were incubated at 37°C for 24h and 100 l of the culture was 
plated into XLT4 agar which was incubated at 37°C overnight. Fecal samples were collected 
from mice every day after Salmonella challenge and Salmonella in the samples were quantified 
by  making  10-fold  dilutions  in  PBS  that  were  then  plated  on  XLT4  agar.  The  plates  were 
incubated at 37°C for 24h. The organs collected at dissection were aseptically cut, macerated 
with a sterile dissecting blade and directly stroked and swabbed onto XLT4 agar and incubated at 
37°C overnight. After swabbing directly onto the plates, these organs were enriched in TET and 
plated onto XLT4 as described for the fecal samples.  
 
RESULTS AND DISCUSSION 
The probiotic strains utilized in this work have been demonstrated to be effective against S. 
Enteritidis in vivo using a broiler chick model [7]. The in vitro results using the Pediococcus 
strain from the present study agreed with these published findings (Table 2), as the Pediococcus 
strain  inhibited  the  growth  of  all  strains  of  Salmonella  that  were  evaluated.  However,  the 
Lactobacillus strain had a limited spectrum of activity and did not inhibit growth in 9 of the 16 
strains of Salmonella (Table 2).  
Similar to our results, published work has demonstrated that some probiotic strains have a 
limited spectrum of activity while other strains were very broadly active against pathogens [14].  
There are several mechanisms of action of the antimicrobial activity of lactic acid bacteria 
including acid production and bacteriocin production. Production of metabolites by lactic acid 
bacteria, including acetic and lactic acid, results in an acidic pH and many pathogens including 
Salmonella are sensitive to acidic pH conditions [15]. However, this variable was accounted for 
by adjusting the pH to nearly neutral prior to suspending the Salmonella and thus, pH cannot 
account for the biocidal activity noted in these experiments. Bacteriocins are also produced by 
lactic  acid  bacteria  and  have  antimicrobial  activity  against  many  pathogens.  Some  of  these 
antimicrobials are not sensitive to pH and retain their activity when pH is changed. Therefore, 
bacteriocins present in the SSM could be responsible for the biostatic activity.  
In  these  experiments,  the  sterile  spent  medium  from  both  strains  of  probiotics  down-
regulated the expression of hilA in the Salmonella strain DT104 (Figure 1).  
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Table 2. Survival of Salmonella cultures after 24 h of suspension in sterile spent MRS medium 
produced by probiotic cultures. The Salmonella cultures were suspended in MRS, incubated at 
37C and optical density (630nm) measured every hour for 24h.  
 
 
Control  Lactobacillus  Pediococcus 
S. Typhimurium DT104  0.965 +0.02  0.95 +0.02  0.822+0.05 
S. Typhimurium ATCC 23595 (LT2)  0.965 +0.02  0.934+0.02  0.75+0.02 
S. Typhimurium ATCC 14028  0.965 +0.02  0.683+0.06  0.52+0.03 
S. Enteritidis (WT)  0.965 +0.02  0.965+0.02  0.82+0.08 
S. Enteritidis ATCC 13076  0.965 +0.02  0.86+0.06  0.717+0.02 
S. Kentucky  0.965 +0.02  0.88+0.04  0.72+0.06 
S. Kentucky  0.965 +0.02  0.96+0.02  0.81+0.02 
S. Seftenburg  0.965 +0.02  0.795+0.06  0.664+0.06 
S. Heidelberg  0.965 +0.02  0.93+0.06  0.75+0.03 
S. Mbandanka  0.965 +0.02  0.96+0.06  0.66+0.02 
S. Newport  0.965 +0.02  0.98+0.02  0.79+0.09 
S. Bairely  0.965 +0.02  0.99+0.03  0.762+0.06 
S. Javana  0.965 +0.02  0.864+0.06  0.754+0.03 
S. Montevideo  0.965 +0.02  0.866+0.06  0.7+0.06 
S. Infantis  0.965 +0.02  0.95+0.06  0.795+0.03 
 
 
Figure 1. Fold change in regulation of hilA (A) and InvA (B) virulence genes in Salmonella 
enterica serovar Typhimurium after suspension in sterile spent medium produced by  
Pediococcus spp. or Lactobacillus acidophilus.        
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However, down-regulation of invA was either absent or not as signficant in the same strain 
of  Salmonella.  These  findings  are  important  because  when  Salmonella  encounters  the 
gastrointestinal environment, transcription of these genes may be activated [16]. Thus methods 
which interfere with regulation of these genes can effectively inhibit colonization.  An acidic pH 
has been demonstrated to supress hilA and invA [17]. Because the pH of the SSM was adjusted 
and  like  biostatic  activity,  pH  cannot  account  for  suppression  of  these  genes.  A  possible 
explanation for the down-regulation may be attriubted to bacteriocins present in the SSM. These 
antimicrobials could have initiated a stress response and therefore, energy efforts were shifted 
away from virulence and allocated towards survival genes [12].  
The probiotic strains utilized in this research did not afford the mice any protection (Table 
3,4). Several mechanism failures may explain the lack of efficacy. First, Letellier et al. [18] 
suggested that to be effective in excluding pathogen infection, a massive colonization of the 
intestinal tract by the probiotic bacteria is required. For this reason, the probiotics used in these 
experiments, may not have colonized to sufficient concentrations to prevent infection. Secondly, 
disruptions to the normal microflora may leave the host more susceptible to infection [19]. This 
may explain why probiotics do not persist after administration is discontinued, as well as the 
failure of long-term changes in the intestinal microbiota using probiotics. In Experiment 1, we 
administered the Lactobacillus and Pediococcus cultures twice prior to challenge. Challenge was 
delivered 24 hours after the probiotics were removed. Thus, it is likely that the host bacterial 
profile had not returned in this short amount of time and instead the probiotics did not afford the 
mice protection from infection for other reasons.   
The performance of probiotic bacterial strains differs because different bacteria have defined 
adherence  sites,  immunological  effects,  and  varied  effects  in  the  healthy  versus  inflamed 
mucosal milieu [2]. In a previous study by Gueimonde et al. [4], 3 strains of Lactobacillus casei 
were evaluated and the authors reported that the strain TMC 0409 was the most effective strain Functional Foods in Health and Disease 2014; 4(8):370-380                                                            Page 377 of 380 
for inhibiting the adhesion of Salmonella Typhimurium ATCC 29631. The authors concluded 
that  the  inhibition  was  related  to  specific  adhesives  and  receptors  for  which  probiotics  and 
pathogens are competing [20]. Additionally, Perdigon et al. [21] demonstrated of 3 probiotic 
bacteria, Lactobacillus casei and Lactobacillus bulgaricus were able to activate macrophages in 
mice  and  suggest  that  these  bacteria,  when  passing  through  the  intestinal  tract,  may  be 
responsible for the enhanced host immune response. Given  these studies, it may be that the 
probiotic bacteria evaluated in these experiments were not as effective in activating immune 
cells. Furthermore, it is also possible that the probiotic bacteria used in these experiments were 
not as specific to the epithelia receptors as other strains have been demonstrated to be [20].  
Typically,  S.  Typhimurium  in  a mouse model  will translocate  across the intestinal  tract 
becoming systemic infecting many of the organs. Furthermore, Salmonella persists for as long as 
30 days post-inoculation, infecting organs but absent from the gastrointestinal tract [19] In this 
study, the results from Experiment 1 support these statements (Table 3). However, it appears that 
in  Experiment  2,  Salmonella  was  colonizing  the  intestinal  tract  as  culturing  recovered 
Salmonella  from  both  fecal  samples  and  intestinal  samples  (Table  4).  The  reason  for  this 
difference is unclear because the mice were given the same challenge dosage of Salmonella in 
both experiment. 
 
Table 3. Detection of Salmonella Typhimurium LT2 in mouse fecal samples and organs after 
necropsy.  Mice  were  administered  probiotic  bacteria  in  the  water  (Lactobacillus  and 
Pediococcus) for 2 days. At day 3, all mice were challenged with  Salmonella Typhimurium 
DT104. Control group (C) and Lactobacillus / Pediococcus (LP).   
1ND=Not detected; D=Detected after enrichment of fecal material in Tetrathionate Broth (TET).  
2 Mice that died prior to the end of the experiment were necropsied immediately after death and 
infected organs are listed in last column. H=heart, L=Lungs, L=Liver, S=Spleen, K=Kidney, C=Cecum, 
In=small intestine 
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Table 4. Detection of Salmonella Typhimurium DT104 in mouse fecal samples and organs after 
necropsy.  Mice  were  administered  probiotic  bacteria  in  the  water  (Lactobacillus  and 
Pediococcus) for 10 days. At day 11, all mice were challenged with Salmonella Typhimurium 
DT104. Control group (C) and Lactobacillus / Pediococcus (LP).         
     
Day Number Post-Salmonella Challenge 
1 ND=Not detected 
2 Mice that died prior to the end of the experiment were necropsied immediately after death 
and infected organs are listed in last column. H=heart, L=Lungs, L=Liver, S=Spleen, K=Kidney, 
C=Cecum, In=small intestine 
 
CONCLUSIONS   
In conclusion, it appears that the probiotic strains used in these experiments had biostatic activity 
in vitro, but did not protect mice from Salmonella infection in vivo. Published studies indicate 
that the reasons may be because there was not a sufficient concentration of probiotic bacteria in 
the intestinal tract and the specificity to epithelial receptors may not have been ideal given that 
the source of these probiotics were from poultry fecal samples. Additionally, the length of time 
between probiotic administration and Salmonella challenge may have been too short to allow 
activation of the immune system in a sufficient manner to enhance protection against infection. 
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